Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH

Richard Torczon

Mylan targets insulin glargine stability patent: LANTUS label & Lougheed art cited against 20 claims as obvious to prevent known insulin aggregation.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Erica A Franklin	400+	56%	69%
Michelle N Ankenbrand	200+	50%	81%
Roberta Pollock	400+	70%	71%

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5A
Richard Torczon	L3A
Jeffrey Guise	L3A
Lorelei Westin	L3D
Douglas H. Carsten	L2B
Nancy L. Zhang	L1B
Nicole W. Stafford	L1B
Clark Lin	L1C
Alina Litoshyk	---- --